V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008832 | 190004758 | 1.65 | 112.1 | Curative (C) | null | 2017-10-16 | Capecitabine + Mitomycin | 02 | null | FLUOROURACIL + OXALIPLATIN | 101215266 |
| 190008834 | 190004759 | null | 87.9 | Palliative (P) | 2016-06-22 | 2016-06-22 | Cetuximab 7 day (>Cycle 2) | 02 | Y | DOCETAXEL | 101678873 |
| 190008835 | 190004760 | 0 | 29.9 | Palliative (P) | 2017-06-29 | 2017-08-25 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101628060 |
| 190008838 | 190004761 | 0 | 0 | Palliative (P) | 2019-09-22 | 2019-09-22 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | EOX | 100110176 |
| 190008845 | 190004762 | 1.82 | 31.9 | Palliative (P) | 2017-06-01 | 2017-06-05 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | FLUOROURACIL + OXALIPLATIN | 100927741 |
| 190008855 | 190004763 | 1.57 | 80.25 | Palliative (P) | 2019-12-28 | 2020-01-04 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | DOCETAXEL + NINTEDANIB | 101595057 |
| 190008856 | 190004764 | 0 | 0 | null | 2018-11-20 | 2019-01-21 | PAM x 2 post-surgery (cycles 3&4) | 02 | null | CAPECITABINE + OXALIPLATIN | 100851357 |
| 190008859 | 190004765 | null | 77.4 | null | 2019-08-30 | 2019-08-30 | Fulvestrant + Ribociclib | 02 | null | VIDE | 101563739 |
| 190008862 | 190004766 | 1.57 | 79.3 | Neo-adjuvant (N) | 2016-07-06 | 2016-10-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101179378 |
| 190008866 | 190004767 | 0 | 28.4 | Curative (C) | 2019-04-20 | 2019-04-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CABAZITAXEL | 101097471 |
| 190008870 | 190004768 | 1.66 | 27.5 | Curative (C) | 2019-06-24 | 2019-06-29 | EURAMOS TRIAL | 02 | N | TRIAL UNSPECIFIED | 100892480 |
| 190008891 | 190004769 | 1.6 | 92.3 | Palliative (P) | 2017-09-22 | 2017-09-28 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | 02 | N | GEMCITABINE | 101394510 |
| 190008894 | 190004770 | 1.6 | 38 | Curative (C) | null | 2020-11-26 | NIVOLUMAB | 01 | N | CAPECITABINE + IRINOTECAN | 100552932 |
| 190008898 | 190004771 | 1.79 | 68.9 | null | 2019-06-20 | 2019-06-20 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100932013 |
| 190008914 | 190004772 | 1.61 | 93.55 | null | 2017-11-20 | 2017-11-27 | Olaratumab | 02 | N | PACLITAXEL | 100464288 |
| 190008915 | 190004773 | 0 | 48.5 | Curative (C) | 2016-04-20 | 2016-04-21 | NIVOLUMAB | null | null | CAPECITABINE + IRINOTECAN | 100328875 |
| 190008923 | 190004775 | 1.63 | 105.2 | Adjuvant (A) | 2020-04-07 | 2020-04-14 | EOX | Y | N | CARBOPLATIN + ETOPOSIDE | 101035732 |
| 190008925 | 190004776 | null | 59.7 | null | 2020-07-10 | 2020-07-12 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100709552 |
| 190008926 | 190004777 | 1.74 | 66.5 | null | 2019-09-03 | 2019-09-06 | Cisplatin | 02 | N | CISPLATIN | 100593261 |
| 190008930 | 190004778 | 1.68 | 72 | Curative (C) | 2017-07-12 | 2017-07-13 | Irinotecan + Modified De Gramont | 02 | null | CAPECITABINE + OXALIPLATIN | 101427877 |
| 190008934 | 190004779 | 1.76 | null | null | 2017-06-03 | 2017-06-04 | null | 02 | N | CAPECITABINE + GEMCITABINE | 101206190 |
| 190008945 | 190004780 | 1.78 | null | Neo-adjuvant (N) | 2019-10-06 | 2019-10-06 | Carboplatin + Etoposide iv&po | 02 | N | TRIAL UNSPECIFIED | 100559012 |
| 190008952 | 190004781 | 1.74 | 73.4 | Palliative (P) | 2021-02-25 | 2021-03-11 | VAC | 02 | N | FULVESTRANT + RIBOCICLIB | 101825577 |
| 190008962 | 190004782 | 1.65 | 55.4 | null | 2020-05-08 | 2020-05-15 | Cisplatin 7 day | 02 | N | CISPLATIN | 101803456 |
| 190008963 | 190004783 | 1.72 | 9.9 | Palliative (P) | 2019-02-07 | 2019-04-05 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | GEMCITABINE | 100339638 |
| 190008964 | 190004784 | 1.48 | 50.05 | Neo-adjuvant (N) | 2020-01-11 | 2020-01-20 | Cisplatin | 02 | N | CISPLATIN | 101529840 |
| 190008968 | 190004785 | 1.55 | 53.6 | Palliative (P) | 2018-09-17 | 2018-10-01 | CARBOPLATIN + PACLITAXEL ALBUMIN (ABRAXANE) | 01 | N | ECX | 100672208 |
| 190008969 | 190004786 | 1.8 | 96 | null | 2020-08-05 | 2020-12-07 | MAP + MIFAMURTIDE | 02 | N | VINCRISTINE | 101317787 |
| 190008970 | 190004787 | 1.73 | 77.1 | Curative (C) | 2016-09-28 | 2016-10-05 | GemCarbo Days 1+8 | 02 | N | CISPLATIN + GEMCITABINE | 101811922 |
| 190008971 | 190004788 | 1.65 | 78 | null | 2019-08-23 | 2020-02-03 | EW Rel rEECur Topotecan/Cyclophosphamide | 01 | N | PEMBROLIZUMAB | 100299477 |
| 190008975 | 190004789 | 1.86 | 53 | Adjuvant (A) | 2018-09-23 | 2018-09-30 | CAPECITABINE + IRINOTECAN | null | Y | DOCETAXEL | 101319053 |
| 190008981 | 190004790 | 0 | 12 | null | 2022-01-31 | 2022-02-01 | Capecitabine | 02 | N | CAPECITABINE + OXALIPLATIN | 101480236 |
| 190008986 | 190004791 | 0 | 76 | Adjuvant (A) | 2019-12-15 | 2019-12-28 | Cetuximab + Radiotherapy Load | 02 | null | CAPECITABINE + OXALIPLATIN | 101100381 |
| 190008992 | 190004792 | 1.73 | 61.3 | Curative (C) | 2018-10-13 | 2018-10-14 | GEMCITABINE + NAB PACLITAXEL | 02 | null | OCTREOTIDE | 100088471 |
| 190008994 | 190004793 | 0 | 50.5 | Palliative (P) | 2020-08-31 | 2020-09-27 | PACLITAXEL | 02 | null | CAPECITABINE + OXALIPLATIN | 101583290 |
| 190008996 | 190004794 | 0 | 23.6 | null | 2017-11-12 | 2018-04-21 | Carboplatin + Etoposide iv&po | N | N | BEVACIZUMAB | 100379288 |
| 190009001 | 190004795 | 1.81 | 67.1 | Curative (C) | 2019-11-04 | 2019-11-04 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100546701 |
| 190009008 | 190004796 | 1.77 | 38.8 | null | 2018-02-09 | 2018-02-10 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 02 | N | TRIAL UNSPECIFIED | 100874159 |
| 190009011 | 190004797 | null | 81 | Palliative (P) | 2018-03-17 | 2018-03-17 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | FLUOROURACIL + OXALIPLATIN | 100810051 |
| 190009014 | 190004798 | 1.81 | 33 | Palliative (P) | 2019-05-05 | 2019-05-06 | VAI (Ifos 3g/m2) | 02 | null | BLEOMYCIN | 100476231 |
| 190009017 | 190004799 | 1.77 | 81.7 | Palliative (P) | 2017-07-18 | 2017-10-30 | EW EuroEwing 2012 Arm A VAC | 2 | Y | LANREOTIDE | 101632890 |
| 190009022 | 190004800 | null | 38 | Neo-adjuvant (N) | 2021-10-21 | 2021-10-21 | CISPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100629178 |
| 190009029 | 190004801 | 1.71 | 98.1 | null | 2017-01-20 | 2017-01-25 | null | 02 | null | CISPLATIN + RT | 100432074 |
| 190009034 | 190004802 | 1.8 | 63.5 | null | 2015-11-18 | 2016-05-05 | Cyclophosphamide + Vincristine | 02 | N | CEMIPLIMAB | 100049352 |
| 190009035 | 190004803 | 1.75 | null | null | 2016-03-09 | 2016-03-17 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100827071 |
| 190009037 | 190004804 | 1.65 | 62 | null | null | 2018-01-20 | Rituximab | null | null | ECX | 100507058 |
| 190009042 | 190004805 | null | 44.9 | null | 2018-01-20 | 2018-11-13 | CISPLATIN + GEMCITABINE | 02 | null | EW EUROEWING 2012 ARM A VAI | 100494068 |
| 190009044 | 190004806 | 1.82 | null | Neo-adjuvant (N) | 2017-02-07 | 2017-02-21 | Carboplatin + Paclitaxel (weekly) | 01 | null | CARBOPLATIN + PACLITAXEL | 101825501 |
| 190009047 | 190004807 | 1.82 | null | null | 2016-11-11 | 2017-03-23 | EW EuroEwing 2012 Arm A/B Zol Acid | N | N | NIVOLUMAB | 101648924 |
| 190009051 | 190004808 | 1.76 | 49.7 | Palliative (P) | 2019-10-05 | 2020-04-01 | Liposomal Doxorubicin 40mg/m2 | 01 | null | CARBOPLATIN + GEMCITABINE | 100985989 |